Sanctuary Advisors LLC Takes Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Sanctuary Advisors LLC purchased a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD) during the second quarter, Holdings Channel reports. The fund purchased 6,266 shares of the medical instruments supplier’s stock, valued at approximately $413,000.

A number of other institutional investors and hedge funds have also made changes to their positions in UTMD. Los Angeles Capital Management LLC increased its stake in Utah Medical Products by 127.0% during the 1st quarter. Los Angeles Capital Management LLC now owns 13,086 shares of the medical instruments supplier’s stock worth $931,000 after buying an additional 7,320 shares during the period. Bridge City Capital LLC increased its stake in Utah Medical Products by 43.4% during the 1st quarter. Bridge City Capital LLC now owns 4,555 shares of the medical instruments supplier’s stock worth $324,000 after buying an additional 1,379 shares during the period. Cardinal Capital Management increased its stake in Utah Medical Products by 25.7% during the 1st quarter. Cardinal Capital Management now owns 14,737 shares of the medical instruments supplier’s stock worth $1,052,000 after buying an additional 3,010 shares during the period. BNP Paribas Financial Markets increased its stake in Utah Medical Products by 123.0% during the 1st quarter. BNP Paribas Financial Markets now owns 8,399 shares of the medical instruments supplier’s stock worth $597,000 after buying an additional 4,633 shares during the period. Finally, Isthmus Partners LLC increased its stake in Utah Medical Products by 56.8% during the 1st quarter. Isthmus Partners LLC now owns 35,602 shares of the medical instruments supplier’s stock worth $2,532,000 after buying an additional 12,903 shares during the period. 69.60% of the stock is owned by hedge funds and other institutional investors.

Utah Medical Products Stock Down 0.4 %

Shares of UTMD opened at $66.27 on Thursday. Utah Medical Products, Inc. has a fifty-two week low of $64.90 and a fifty-two week high of $87.86. The firm’s 50 day moving average price is $66.81 and its 200 day moving average price is $67.76. The company has a market cap of $230.62 million, a P/E ratio of 15.30 and a beta of 0.08.

Utah Medical Products (NASDAQ:UTMD) last announced its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 earnings per share for the quarter. Utah Medical Products had a net margin of 33.56% and a return on equity of 12.41%. The firm had revenue of $10.40 million for the quarter.

Utah Medical Products Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 4th. Shareholders of record on Friday, September 20th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date was Friday, September 20th. Utah Medical Products’s dividend payout ratio is presently 27.71%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.